This article was published more than 2 years agoCommentGift ShareA nationwide sense of relief grew Tuesday as a second appeared poised for approval just days after thousands of health-care workers received doses of the first one in an unprecedented mass inoculation campaign that has raised hopes for a return to normalcy.The second vaccine, developed by the biotechnology company Moderna, was “highly effective” in a clinical trial and carried no serious safety concerns, according to a detailed review by the Food and Drug Administration published Tuesday. The agency is likely to authorize...…This article was published more than 2 years agoCommentGift ShareA nationwide sense of relief grew Tuesday as a second appeared poised for approval just days after thousands of health-care workers received doses of the first one in an unprecedented mass inoculation campaign that has raised hopes for a return to normalcy.The second vaccine, developed by the biotechnology company Moderna, was “highly effective” in a clinical trial and carried no serious safety concerns, according to a detailed review by the Food and Drug Administration published Tuesday. The agency is likely to authorize...WW…